Benzinga | Aug 3, 2020 04:05PM EDT

Pacific Biosciences Q2 EPS $(0.15) Beats $(0.18) Estimate, Sales $17.10M Beat $13.72M Estimate

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.18) by 16.67 percent. This is a 6.25 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $17.10 million which beat the analyst consensus estimate of $13.72 million by 24.64 percent. This is a 30.55 percent decrease over sales of $24.62 million the same period last year.